510(k) Report

510(k) · Cleared

Recalled · Class I · 2018

VIAL2BAG

K072759510(k) AbbreviatedCleared Dec 13, 200776-day reviewClass II21 CFR 880.5440Recalls 1 (1 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medimop Medical Projects, Ltd. · LHI Set, I.V. Fluid Transfer

Cleared on Dec 13, 2007 as substantially equivalent to K040634 (Halkey-Roberts Corp., 2004) and 2 other predicates after a 76-day review. Its family tree reaches back 4 generations to 1988. 2 of the 13 devices in its family, counting itself, have a Class I recall. 2 later devices descend from it. It has been recalled once, including a Class I recall.

Decided
Dec 13, 2007
Review
76 days
Class
Class II
Product code
LHI
Recalls
1 (1 Class I)
Predicates
3

Its longest line of descent runs back 4 generations to K883614 (1988). 10 ancestors in all, the oldest K790472 (1979). 2 later devices descend from it, 1 citing it directly. 2 of the 13 devices in this family, counting this one, have a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2004: 1 other ancestor2001: 1 other ancestor1995: 1 other ancestor1994: 2 other ancestors1979: 1 other ancestor2014: 1 descendant cleared2017: 1 descendant cleared, 1 with a Class I recall1K883614 · Cytoguard (R) · Survival Technology, Inc. · 1988×2: 2 generations cleared close together, K972527 (1997), K980381 (1998) K051669 · Tevadaptor Closed Drug Reconstitution and Transfer System · Migada Plant · 2005 · recalled19801990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 1 other ancestor3 generations back: 4 other ancestors 1 generation forward: 1 descendant2 generations forward: 1 descendant, 1 with a Class I recall1 K051669 · Tevadaptor Closed Drug Reconstitution and Transfer System · Migada Plant · 2005 · recalledK980381 · Phaseal, Closed System Forhandling of Parenteral Drugs, Additional Administration Devices. C80 Infusion Adapter, A10 Pro · Carmel Pharma Ab. · 1998K972527 · Phaseal, System for Sealed Handling of Chemotherapeutic Agents · Quality System Consulting · 1997K883614 · Cytoguard (R) · Survival Technology, Inc. · 19880
  1. Root · 4 generations backK883614 Cytoguard (R)Survival Technology, Inc. · 1988
  2. 3 generations backK972527 Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting · 1997
  3. 2 generations backK980381 Phaseal, Closed System Forhandling of Parenteral Drugs, Additional…Carmel Pharma Ab. · 1998
  4. 1 generation backK051669 Tevadaptor Closed Drug Reconstitution and Transfer SystemMigada Plant · 2005 · Recalled
  5. This deviceK072759 VIAL2BAGMedimop Medical Projects, Ltd. · 2007
  6. Descendant · cites it directly · 1 of its ownK140730 VIAL2BAG Direct ConnectMedimop Medical Projects, Ltd. · 2014 · Recalled
  7. Descendant · 2 generations on · 0 of its ownK170095 Vial2Bag Direct ConnectMedimop Medical Project, Ltd. · 2017 · Recalled (Class I)

Class I recalls in this family

Most influential descendants

Showing 2 of 2 · See all
  • K140730VIAL2BAG Direct ConnectMedimop Medical Projects, Ltd. · 2014 · cites it directly1descendant
  • K170095Vial2Bag Direct ConnectMedimop Medical Project, Ltd. · 2017 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K883614Cytoguard (R)Survival Technology, Inc.1988—
−3K972527Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting1997—
−2K980381Phaseal, Closed System Forhandling of Parenteral Drugs, Additional…Carmel Pharma Ab.1998—
−1K051669Tevadaptor Closed Drug Reconstitution and Transfer SystemMigada Plant20051
0 (this device)K072759VIAL2BAGMedimop Medical Projects, Ltd.2007—
+1K140730VIAL2BAG Direct ConnectMedimop Medical Projects, Ltd.20141
+2K170095Vial2Bag Direct ConnectMedimop Medical Project, Ltd.2017Class I

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
197910
199420
199510
200110
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
201711
FIG. 1 — Lineage of K072759, 1988–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LHI device

  1. #1 K252987 ADRx™ Admixture Devicescore 12.4 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K040634Robertsite Vial Adapter, Model 245700021
Summary page 1
…ice name: Same as Trade name Predicate devices: ROBERTSITE VIAL ADAPTER 510(k) No. K040634 Halkey-Roberts PHASEAL INFUSION ADAPTER…
Halkey-Roberts Corp.2004—
*K980381Phaseal, Closed System Forhandling of Parenteral Drugs, Additional Administration…
Summary page 1
…Halkey-Roberts PHASEAL INFUSION ADAPTER 510(k) No. K980381 Carmel Pharma TEVADAPTOR, DRUG RECONSTITUTI…
Carmel Pharma Ab.1998—
*K051669Tevadaptor Closed Drug Reconstitution and Transfer System
Summary page 1
…Carmel Pharma TEVADAPTOR, DRUG RECONSTITUTION AND TRANSFER SYSTEM 510(k) No. K051669 Teva Manufacturer: Medimop Medical Projects Ltd.…
Migada Plant20051

Also cleared against K040634: 2 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K140730VIAL2BAG Direct ConnectMedimop Medical Projects, Ltd.20141

Has anything in its family been recalled? (2 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 26, 2018Class IZ-0768-2019Device DesignAdverse events have been reported with the use of oxytocin in conjunction with the 13mm Vial2Bag DC in pregnant women. Vial2Bag is recalled due to similarities with 13mm Vial2Bag DC.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K170095Vial2Bag Direct ConnectMedimop Medical Project, Ltd. · 2017 · 2 generations on · ◆ in the 2017 descendants bar of FIG. 12 Class I recalls

What does this lineage say?

  • The line of descent spans 19 years and passes through 5 companies; a new generation was cleared every 7.5 years on median.
  • 2 of the 10 ancestors have a recall of any class.
  • Of its descendants, K140730 (Medimop Medical Projects, Ltd., 2014) has gone furthest, with 1 descendant of its own.
  • 2 other devices also cite its predicate K040634.

How does its category compare?

All LHI devices

LHI Set, I.V. Fluid Transfer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · LHI

6in 2025

2007: 32008: 42009: 82010: 52011: 32012: 52013: 42014: 62015: 32016: 32017: 52018: 12019: 42020: 32021: 32022: 62023: 52024: 92025: 62026 (partial year): 2
2007high 9 (2024) · low 1 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LHI

196in 2025

2007: 89 days median2008: 154 days median2009: 95 days median2010: 139 days median2011: 99 days median2012: 127 days median2013: 102 days median2014: 63 days median2015: 99 days median2016: 159 days median2017: 56 days median2019: 247 days median2020: 189 days median2021: 396 days median2022: 278 days median2023: 90 days median2024: 166 days median2025: 196 days median
2007high 396 (2021) · low 56 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LHI

1in 2024

2007: 12008: 32009: 12010: 32011: 122013: 32016: 1, 1 Class I2017: 12018: 3, 3 Class I2019: 12022: 22023: 2, 2 Class I2024: 12026 (partial year): 1
2007high 12 (2011) · low 0 (2012)2026

Class I (6 since 2007) Class II/III not classified

Adverse event reports per year · LHI

1,334in 2025

2007: 182008: 272009: 372010: 492011: 1552012: 5292013: 1542014: 1552015: 1282016: 2192017: 5362018: 1,4992019: 1,6342020: 1,1712021: 9332022: 1,8342023: 1,0472024: 1,2702025: 1,334
2007high 1,834 (2022) · low 18 (2007)2025

MAUDE reports naming product code LHI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007389118
20084154327
2009895137
20105139349
201139912155
201251270529
201341023154
20146630155
20153990128
201631591 (1)219
20175561536
20181—3 (3)1,499
2019424711,634
2020318901,171
202133960933
2022627821,834
20235902 (2)1,047
2024916611,270
2025619601,334
20262—1—

What is it indicated for?

The Vial2Bag is indicated to serve as a connecting part between the IV bag and an external IV Line. The Vial2Bag has a built in connector which makes it possible to admix drugs into the infusion solution using a Swabable Valve.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K072759: VIAL2BAG.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K072759

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026